Beek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander

Beek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES: Molecular SC144 custom synthesis Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring. Science 1999, 286(5439):531-537[http://dx. doi.org/10.1126/science.286.5439.531]. 27. Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR, Korsmeyer SJ: MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nature Genetics 2002, 30:41-7[http:// www.ncbi.nlm.nih.gov/pubmed/11731795]. 28. Ross ME, Mahfouz R, Onciu M, Liu HC, Zhou X, Song G, Shurtleff SA, Pounds S, Cheng C, Ma J, Ribeiro RC, Rubnitz JE, Girtman K, Williams WK, Raimondi SC, Liang DC, Shih LY, Pui CH, Downing JR: Gene expression profiling of pediatric acute myelogenous leukemia. Blood 2004, 104(12):3679-3687[http://dx.doi.org/10.1182/blood-2004-03-1154]. 29. Yeoh E, ME R, SA S, WK W, D P, R M, FG B, SC R, MV R, A P, C C, D C, D W, X Z, J L, H L, CH P, WE E, C N, L W, JR D: Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002, 1(2):133-143. 30. Krishna D, LeDoux J: Murine leukemia virus particles activate Rac1 in HeLa cells. Biochem Biophys Res Commun 2006, 345(3):1184-93. 31. Wang J, Rao Q, Wang M, Wei H, Xing H, Liu H, Wang Y, Tang K, Peng L, Tian Z, Wang J: Overexpression of Rac1 in leukemia patients and its role in leukemia cell migration and growth. Biochem Biophys Res Commun 2009, 386(4):769-74. 32. Booden MA, Siderovski DP, Channing JD: Leukemia-associated Rho guanine nucleotide exchange factor promotes G alpha q-coupled activation of RhoA. Molecular and cellular biology 2002, 22(12):4053-61. 33. Kristelly R, Gao G, Tesmer JJG: Structural Determinants of RhoA Binding and Nucleotide Exchange in Leukemia-associated Rho GuanineNucleotide Exchange Factor. The Journal of Biological Chemistry 2004, 279:47352-47362. 34. Katzav S: Flesh and blood: the story of Vav1, a gene that signals in hematopoietic cells but can be transforming in human malignancies. Cancer Lett 2007, 255(2):241-54. 35. Juliana L, Andrew Y, Jr FSA, Bing Y, de los Santos K, Goff SP: Interaction of Moloney murine leukemia virus matrix protein with IQGAP. The EMBO Journal 2006, 25:2155- 2166. 36. Balagopal P, Olney R, Darmaun D, Mougey E, Dokler M, Sieck G, Hammond D: Oxandrolone enhances skeletal muscle myosin synthesis and alters global gene expression profile in Duchenne muscular dystrophy. Am J Physiol Endocrinol Metab 2006, 290(3):E530-9. 37. Baker P, Kearney J, Gong B, Merriam A, Kuhn D, Porter J, Rafael-Fortney J: Analysis of gene expression differences between utrophin/dystrophindeficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles. Neurogenetics 2006, 7(2):81-91. 38. Garvey S, Rajan C, Lerner A, Frankel W, Cox G: The muscular dystrophy PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/25609842 with myositis (mdm) mouse mutation disrupts a skeletal muscle-specific domain of titin. Genomics 2002, 79(2):146-9. 39. Hackman P, Vihola A, Haravuori H, Marchand S, Sarparanta J, Seze JD, Labeit S, Witt C, Peltonen L, Richard I, Udd B: Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. American Journal of Human Genetics 2002, Sep 71(3):492-500. 40. Itoh-Satoh M, Hayashi T, Nishi H, Koga Y, Arimura T, Koyanagi T, Takahashi M, Hohda S, Ueda K, Nouchi T, Hiroe.